Drug delivery and diagnostic disposables sees a global capacity addition, also witnesses a beginning of strategic alliance between medical device behemoth BD and CTP

Global capacity of drug delivery and diagnostic disposables sees a recent expansion by addition of CTP’s manufacturing facility.

While innovation in drug delivery has been on steady pace, joint alliances between medtech OEMs and contract manufacturers has been pretty much stagnant.

CTP, along with expanding its annual production volume also struck a deal with BD for commercial launch of BD Vystra, a disposable pen for delivering insulin and other injectable drugs. CTP had previously supported Becton Dickinson with pilot phase of Vystra.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s